An Observational Study to Assess the Protocol for the COVID-19 Treatment in Burkina Faso

NCT04445441 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 153

Last updated 2021-01-22

No results posted yet for this study

Summary

This is an observational study to evaluate the effectiveness of the combinations Hydroxychloroquine + Azithromycin (HCQ-AZ) and Chloroquine + Azithromycin (CQ-AZ) in the treatment of Coronavirus (Covid-19) infection in Burkina Faso.

Conditions

  • Coronavirus Infection

Sponsors & Collaborators

  • Centre Muraz

    lead OTHER

Principal Investigators

  • Halidou Tinto, PhD · IRSS - URCN

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-24
Primary Completion
2020-09-03
Completion
2020-11-30

Countries

  • Burkina Faso

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04445441 on ClinicalTrials.gov